Medical Devices & Products - Australia

Value added in the Medical Devices & Products market is projected to amount to US$2.6bn in 2024.
A compound annual growth rate of 1.52% is expected (CAGR 2024–2029).
The value added per capita in the Medical Devices & Products market is projected to amount to US$95.9 in 2024.
The value added margin in the Medical Devices & Products market is projected to amount to 27% in 2024.
Output in the Medical Devices & Products market is projected to amount to US$9.3bn in 2024.
A compound annual growth rate of 1.40% is expected (CAGR 2024–2029).
The output per enterprise in the Medical Devices & Products market is projected to amount to US$7.5m in 2024.
The manufacturing intensity in the Medical Devices & Products market is projected to amount to 0.6% in 2024.
The number of enterprises in the Medical Devices & Products market is projected to amount to 1.24k in 2024.
A compound annual growth rate of 1.90% is expected (CAGR 2024–2029).
The enterprise density in the Medical Devices & Products market is projected to amount to 46 in 2024.
The number of employees in the Medical Devices & Products market is projected to amount to 18.61k in 2024.
A compound annual growth rate of 1.52% is expected (CAGR 2024–2029).
The employment rate in the Medical Devices & Products market is projected to amount to 0.07% in 2024.
The labor efficiency in the Medical Devices & Products market is projected to amount to US$501.9k in 2024.
The labor productivity in the Medical Devices & Products market is projected to amount to US$137.6k in 2024.

Definition:

The Medical Devices & Products market refers to the manufacturing of pharmaceutical products and medical devices.

Additional information:

The market comprises value added, output, number of enterprises, number of employees, and the respective growth rates. Output refers to the total value of all goods produced, whereas value added is the sum of the intermediate stages of production or, in other words, the wealth created by industry activity. The market only displays B2B production.

Manufacture of medicinal active substances
Manufacture of medicaments
Other categories listed in ISIC Classes 2100 and 3250

Wholesale, retail sale of pharmaceuticals
Research and development for pharmaceuticals and biotech pharmaceuticals
Packaging of pharmaceuticals
Manufacture of electromedical and electrotherapeutic equipment
Manufacture of wheelchairs

The manufacturing market has faced several challenges in recent years due to geopolitical uncertainty, supply chain disruptions, changing consumer preferences, and increasing regulatory scrutiny. However, several positive factors, such as rising global demand, ongoing technological advancements, and increasing investment in automation and digitalization, continue to influence the market, and the outlook for manufacturing remains positive.

While the Covid-19 pandemic has caused significant hardships for manufacturers, those that invested in digitalization and automation of their processes will be best positioned for long-term success. Manufacturers who can effectively balance cost pressures and maintain a strong focus on quality are likely to survive the current crisis and come out more resilient in the end.

Among the factors that could affect the manufacturing market in 2023 is the adoption of advanced technology, such as artificial intelligence, robotics, and the Internet of Things (IoT), which have the potential to improve overall efficiency and productivity while reducing costs.

Furthermore, our analysts believe that sustainability and environmental awareness will become increasingly important trends, as more investors and consumers prefer companies that prioritize these values and develop eco-friendly products.

Finally, geopolitical factors such as trade tensions and changes in government policies could also impact the manufacturing market in 2023, with the Russia-Ukraine war having the biggest impact.

In summary, the current environment presents both challenges and opportunities for the manufacturing market in 2023. However, with the right managerial strategies and high flexibility, companies can succeed and strengthen their long-term market position.

Data coverage:

The data encompasses B2B. Figures are based on the value added in the manufacturing market.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market. As a basis for evaluating markets, we use resources from the Statista platform as well as annual financial reports of the market-leading companies and industry associations, third-party studies and reports, national statistical offices, international institutions, and the experience of our analysts. In addition, we use relevant key market indicators and data from country-specific associations, such as GDP, consumer spending, and consumer price index.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, the S-curve function and exponential trend smoothing are well suited for forecasting the manufacturing market due to the non-linear growth of this market.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year.

This report presents a comprehensive analysis and additional information on the Industrial market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.